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Abstract 
Eosinophil-associated diseases represent a spectrum of heterogeneous disorders, where 
blood and cutaneous eosinophilia is the most important feature and eosinophils are the 
principal cause of cutaneous lesions. These diseases show some similarities in the clinical 
features but also many distinctive characteristics [Saurat et al., Dermatologia e malattie 
sessualmente trasmesse, Milano, Masson, 2000]. Wells syndrome is one of these disorders 
and is an uncommon recurrent inflammatory dermatosis, rarely associated to signs and 
symptoms of multiple organ involvement [Arch Dermatol 2006;142:1157–1161]. 
Hypereosinophilic syndrome, in contrast, constitutes a group of idiopathic disorders 
characterized by blood eosinophilia for at least 6 months, associated with single or 
multiple organ system dysfunction [Arch Dermatol 2006;142:1157–1161]. Clinically 
atypical Wells syndrome with multiorgan involvement is reported here. A correct 
diagnosis is difficult in this case, but clinical and histopathological features are 
compatible with this diagnosis. The reported condition likely represents a borderline 
hypereosinophilic disease, in which clinical features of both hypereosinophilic syndrome 
and Wells syndrome are present. 
 
Introduction 
Wells syndrome is an uncommon recurrent inflammatory dermatosis of unknown 
aetiology with distinctive but unspecific histopathological features and clinical 
polymorphism [1]. It is characterized in most cases by large erythematous and  
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oedematous plaques of annular or circinate morphology, resolving without any outcome 
[2]. Histopathological findings consist of dermal eosinophilic infiltration and ‘flame 
figures’, an aggregation of eosinophils among the dermal collagen bundles. This condition 
is rarely associated with systemic involvement, but peripheral blood eosinophilia is 
common [3]. The course of this dermatosis may be subacute for months or years, with 
complete resolution, and possible recurrence after long periods [2]. 
In contrast, hypereosinophilic syndrome (HES) constitutes a group of idiopathic 
disorders associated with multiple organ dysfunction, sometimes fatal. The criteria of 
diagnosis are: persistent idiopathic blood eosinophilia, at least for 6 months; signs or 
symptoms of organ involvement (haematological, cardiac, pulmonary, rheumatological, 
gastrointestinal, musculoskeletal, neurological disorders) [4]. Cutaneous manifestations 
are pruritic or erythematous papules, plaques and nodules, with urticaria and 
angio-oedema, present in more than half of the cases [3, 4]. Histopathological findings are 
unspecific with variable dermal infiltration of mixed inflammatory cells, including 
eosinophils, without evidence of flame figures, because there is insufficient degranulation 
of eosinophils in the skin [1]. 
Herein we report a case that showed clinical features of Wells syndrome, but was 
associated with a diversity of systemic signs and symptoms (parotid glands, pancreas and 
lungs). 
Case Report 
A 69-year-old man was referred to our department in February 2007 with pruritic erythematous and 
oedematous plaques, papulovesicular lesions and some large blisters particularly localised on the trunk 
and extremities. The patient showed marked bilateral parotid enlargement with involvement of the face, 
neck and upper surface of the trunk. The submandibular lymph nodes were swelled. Dermatological 
features consisted of erythematous lesions that were observed on the upper legs (fig. 1). General 
symptoms were fever (38–39ºC) and fatigue. His initial blood count showed a white cell count 12.3 × 
10
6/l with 31.5% eosinophils and 15.7% lymphocytes. Nevertheless stool was negative for ova and 
parasites, no viral infection was demonstrated, there was no evidence of allergic disease or eosinophilic 
leukemia. We also investigated the hypothesis that constitutional genetic variation in IL-5 signalling 
might be involved in this condition, but the results of the molecular analysis were negative, bone 
marrow tests were negative, and there was not evidence of monoclonal T-cell population. Other 
laboratory exams were normal or negative, and serological tests, including the assays of the main 
autoantibodies, complement, circulating immunocomplexes and tumour markers were 
non-contributory. A skin biopsy specimen taken from the site of oedematous erythema on the left upper 
leg revealed, at histology, a diffuse and heavy infiltrate of eosinophils in the dermis with extension into 
the underlying subcutaneous tissue. 
Treatment with intravenous corticosteroids (betamethasone 4 mg/day) was finally started, but the 
levels of eosinophils fluctuated with the course of the disease, reaching a maximum of 5,400/μl and, at 
the same time, amylase levels increased to 256 U/l (normal 8–53 U/l) and lipase levels to 2,400 U/l 
(normal 20–300 U/l). Therefore, instrumental investigations were made: abdominal ultrasound did not 
show any relevant alteration in the liver and spleen, and chest X-ray and echocardiography were in the 
normal range. Total body computerized tomography finally showed a marked bilateral enlargement of 
the parotid and submandibular glands, the presence of a little pancreas enlargement and a pulmonary 
embolism, supported by increased D-dimer levels (800 mg/l). 
Typical clinical picture, negative IMF, absence of associated immunomediated systemic diseases, and 
blood eosinophilia suggested that, in spite of the absence of flame figures, not present in every stage of 
Wells eosinophilic cellulitis, the case could be classified as Wells syndrome. Anticoagulant therapy was 
started (heparin s.c. 8,000 IU/day) associated with corticosteroid therapy with methylprednisolone 
(16 mg/day). After a month of therapy, in which the steroid dose was gradually tapered, we observed 
complete clearance of the skin lesions and normalization of blood eosinophil count and pancreatic 
enzymes (amylase and lipase) levels.  
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Discussion 
Wells syndrome (or eosinophilic cellulitis) was first described by Georg Crichton Wells 
in 1971, who named it ‘recurrent granulomatosus dermatitis with eosinophilia’; in 1979 
this definition was modified to ‘eosinophilic cellulitis’ or ‘Wells syndrome’ [1]. Clinically, 
in most cases, it is characterized by annular or circinate erythematous-oedematous 
plaques, but a wide variety of clinical pictures have been described, including blistering, 
nodules, papulovescicular eruptions and excoriated papules [5]. It is considered as a 
distinct entity, and seven clinical variants of this disease are described: plaque-type, 
annular granuloma-like, urticaria-like, papulovesicular, bullous, papulonodular and fixed 
drug eruption-like [5]. Histopathological features can be categorized into three different 
phases: acute, subacute and regressive. The acute phase is characterized by oedema of 
superficial dermis and middermis with eosinophilic infiltrate; in the subacute phase flame 
figures in the dermis can be noted, consisting of eosinophilic major basic protein 
deposited on collagen bundles and widespread degranulation of eosinophils; the 
regressive phase, instead, is characterized by disappearance of eosinophils with 
persistence of histiocytes and microgranulomas composed of giants cells, deposited 
around collagen deposits [1]. Flame figures are an important histological feature of Wells 
syndrome, but are not present in every phase and are not pathognomonic of this disease; 
in fact, they can be associated with other dermatologic conditions such as pemphigoid, 
eczema, prurigo, tinea infection, herpes gestationis, cutaneous mastocytoma and scabies 
[2, 6, 7]. The course of this condition is almost invariably benign, with episodic 
remissions and relapses. 
HES is an idiopathic condition characterized by persistent eosinophilia for at least 
6 months, with involvement of one or more organs. The heart, lungs, nervous system, 
liver and skin are commonly affected [8]. Diagnosis of this disease always requires a 
careful exclusion of other pathological conditions in which eosinophilia is present, in 
particular parasitic infection; it has been also reported in association with systemic 
diseases such as T-cell lymphoma, mast cell disease and HIV infection [4, 9]. Cutaneous 
lesions are present in about 50% of patients and usually consist of pruritic papules and 
nodules, or urticaria and angioedema. Oral and genital erosions are quite characteristic 
and may be the first manifestation of the disease [10]. Recently three types have been 
characterized: myeloproliferative HES, lymphocytic HES and other heterogeneous clinical 
conditions (unclassified HES). Myeloproliferative HES can be differentiated by 
eosinophilic leukemia for the presence of mature eosinophils and for absence of clonal 
expansion. Lymphocytic HES is characterized by T-cell clonality, in particular 
CD3+CD4–CD8– and CD3–CD4+. This disease presents, in general, a benign course, but 
some patients can develop a lymphoma. The term ‘unclassified HES’ includes different 
entities, such as Gleich syndrome (episodic angioedema and eosinophilia) and NERDS 
(disseminated nodules, eosinophilia, rheumatism and dermatitis), that present also a 
T-cell clonality. Recent advances in the pathogenesis of this condition have established 
that hypereosinophilia may be triggered either by a primitive involvement of myeloid cells 
due to the occurrence of an interstitial chromosomal deletion on 4q12, which generates a 
FIP1L1-PDGFRA fusion gene (F/P
+ variant), or by an increased IL-5 production that 
follows a clonal expansion of the T-cell population (lymphocytic variant), most frequently 
characterized by a CD3–CD4+ phenotype [10]. 
The association of Wells syndrome and HES has occasionally been reported. 
Heterogeneity of symptoms and association with other diseases led to doubted the 
identity of Wells syndrome. Aberer et al. [7], in 1988, postulated that it might be 
considered as a distinctive entity and not only as a clinical and histological reaction to  
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several conditions. In contrast, other authors postulated that this syndrome could be 
considered as a cutaneous manifestation of HES [1, 3]. In fact, clinical and 
histopathological findings of both syndromes may overlap, suggesting that this condition 
may represent, at least for some patients, the benign evolution of HES [4]. 
In our patient we could exclude the diagnosis of HES bacause of the absence of 
persistent eosinophilia, of clinical features and of molecular alterations typical of this 
syndrome. However, we could support the diagnosis of Wells syndrome. Wells syndrome 
and HES, at least in some of the cases, should be considered as part of a spectrum of 
hypereosinophilic disorders triggered by causative agents that include insect bites, 
arthropod bites, onchocerciasis, varicella, mumps, drug reactions, atopic diathesis, fungal 
infection, carcinomas, haematological diseases and eosinophilic myositis [2, 11–14]. In 
the literature there are few cases of Wells syndrome associated with haematological 
malignancies and cases with underlying nonhaematological malignancies (squamous cell 
carcinoma, nasopharyngeal carcinoma and colon carcinoma) or liver involvement 
reported [15, 16], but none with a simultaneous involvement of the parotid glands and 
the pancreas or pulmonary embolism. 
In our opinion, in the next future molecular and immunological studies, directed to 
better understand the pathophysiology of nonneoplastic eosinophilic proliferation, will 
contribute to better clarify the nosological classification of these intriguing pathological 
conditions. 
 
 
 
 
 
Fig. 1. a Marked bilateral parotid enlargement on the face and neck. b Erythematous lesions of the 
upper leg. 
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